Home » Topics » Science » Drug design, drug delivery and technologies

Drug design, drug delivery and technologies
RSS

Pharmacopeia and Otsuka enter drug discovery collaboration

Nov. 18, 1999

Genetronics and Boehringer Ingelheim enter collaborative gene therapy agreement

Nov. 12, 1999

CombiChem reaches second milestone in collaboration with Teijin

Nov. 10, 1999

Exelixis and Pharmacia & Upjohn expand collaboration

Nov. 10, 1999

ASN presentation for VNA-932, a potent and selective, nonpeptide V2 agonist

Nov. 9, 1999

Helix BioPharma finalizes acquisition of PharmaDerm

Nov. 9, 1999

Idun identifies X-ray structure of caspase 8

Nov. 8, 1999

Abgenix and Pfizer add third antigen target to collaboration agreement

Nov. 5, 1999

HepaVec and CSIRO sign option agreement for ovine viral vector technology

Oct. 25, 1999

Mechanistically novel iNOS inhibitors identified during Pharmacopeia/Berlex joint project

Oct. 22, 1999

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 24, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Dec. 24, 2025.
Researchers discover how glioblastoma tumors dodge chemotherapy
BioWorld MedTech
Researchers at the University of Sydney have uncovered a mechanism that may explain why glioblastoma returns after treatment, and the world-first discovery offers...
HIV research is close to a cure but far from ending the pandemic
BioWorld
Advances in antiretroviral therapy (ART) now allow people living with HIV to lead normal lives with undetectable and nontransmissible levels of the virus in their...
ADEL wins $1.04B Sanofi deal for tau-targeting Alzheimer’s drug
BioWorld
ADEL Inc. closed a year-end licensing deal worth up to $1.04 billion with Sanofi SA for ADEL-Y01, a specific tau-targeting Alzheimer’s disease drug candidate in a...